Trials / Conditions / ALK-negative Anaplastic Large Cell Lymphoma
ALK-negative Anaplastic Large Cell Lymphoma
3 registered clinical trials studyying ALK-negative Anaplastic Large Cell Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms NCT03493451 | BeiGene | Phase 2 |
| Unknown | CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL NCT02533700 | Shandong Provincial Hospital | Phase 2 |
| Unknown | CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymph NCT01746992 | Ruijin Hospital | Phase 4 |